{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T19:55:22Z","timestamp":1686254122672},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2008,11,8]],"date-time":"2008-11-08T00:00:00Z","timestamp":1226102400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Anaesthesist"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1007\/s00101-008-1459-y","type":"journal-article","created":{"date-parts":[[2008,11,6]],"date-time":"2008-11-06T17:13:31Z","timestamp":1225991611000},"page":"1172-1182","source":"Crossref","is-referenced-by-count":3,"title":["Cholostase und Leberinsuffizienz beim Intensivpatienten"],"prefix":"10.1007","volume":"57","author":[{"given":"M.","family":"Kredel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Brederlau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Roewer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Wunder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,11,8]]},"reference":[{"key":"1459_CR1","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S1089-3261(05)70004-0","volume":"2","author":"Sherlock","year":"1998","unstructured":"Sherlock S (1998) Overview of chronic cholestatic conditions in adults: terminology and definitions. Clin Liver Dis 2(2): 217\u2013233 vii","journal-title":"Clin Liver Dis"},{"key":"1459_CR2","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1056\/NEJM200004273421707","volume":"342","author":"Pratt","year":"2000","unstructured":"Pratt DS, Kaplan MM (2000) Evaluation of abnormal liver-enzyme results in asymptomatic patients. N Engl J Med 342(17): 1266\u20131271","journal-title":"N Engl J Med"},{"key":"1459_CR3","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1378\/chest.104.1.230","volume":"104","author":"Hebert","year":"1993","unstructured":"Hebert PC, Drummond AJ, Singer J et al. (1993) A simple multiple system organ failure scoring system predicts mortality of patients who have sepsis syndrome. Chest 104(1): 230\u2013235","journal-title":"Chest"},{"key":"1459_CR4","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1097\/00003246-199510000-00007","volume":"23","author":"Marshall","year":"1995","unstructured":"Marshall JC, Cook DJ, Christou NV et al. (1995) Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med 23(10): 1638\u20131652","journal-title":"Crit Care Med"},{"key":"1459_CR5","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1001\/archsurg.1985.01390340007001","volume":"120","author":"Goris","year":"1985","unstructured":"Goris RJ, Boekhorst TP te, Nuytinck JK, Gimbrere JS (1985) Multiple-organ failure. Generalized autodestructive inflammation? Arch Surg 120(10): 1109\u20131115","journal-title":"Arch Surg"},{"key":"1459_CR6","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1097\/00003246-199811000-00016","volume":"26","author":"Vincent","year":"1998","unstructured":"Vincent JL, Mendonca A de, Cantraine F et al. (1998) Use of the SOFA score to assess the incidence of organ dysfunction\/failure in intensive care units: results of a multicenter, prospective study. Working group on \u201esepsis-related problems\u201c of the European Society of Intensive Care Medicine. Crit Care Med 26(11): 1793\u20131800","journal-title":"Crit Care Med"},{"key":"1459_CR7","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00134-005-0023-3","volume":"32","author":"Brienza","year":"2006","unstructured":"Brienza N, Dalfino L, Cinnella G et al. (2006) Jaundice in critical illness: promoting factors of a concealed reality. Intensive Care Med 32(2): 267\u2013274","journal-title":"Intensive Care Med"},{"key":"1459_CR8","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1097\/01.CCM.0000259462.97164.A0","volume":"35","author":"Kramer","year":"2007","unstructured":"Kramer L, Jordan B, Druml W et al. (2007) Incidence and prognosis of early hepatic dysfunction in critically ill patients \u2013 A prospective multicenter study. Crit Care Med 35(4): 1099\u20131104","journal-title":"Crit Care Med"},{"key":"1459_CR9","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/00005373-200209000-00020","volume":"53","author":"Harbrecht","year":"2002","unstructured":"Harbrecht BG, Zenati MS, Doyle HR et al. (2002) Hepatic dysfunction increases length of stay and risk of death after injury. J Trauma 53(3): 517\u2013523","journal-title":"J Trauma"},{"key":"1459_CR10","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s00423-001-0269-3","volume":"387","author":"Lefering","year":"2002","unstructured":"Lefering R, Goris RJ, Nieuwenhoven EJ van et al. (2002) Revision of the multiple organ failure score. Langenbecks Arch Surg 387(1): 14\u201320","journal-title":"Langenbecks Arch Surg"},{"key":"1459_CR11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S1089-3261(03)00136-3","volume":"8","author":"Sotil","year":"2004","unstructured":"Sotil EU, Jensen DM (2004) Serum enzymes associated with cholestasis. Clin Liver Dis 8(1): 41\u201354 vi","journal-title":"Clin Liver Dis"},{"key":"1459_CR12","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S0016-5085(72)80154-9","volume":"62","author":"Kaplan","year":"1972","unstructured":"Kaplan MM (1972) Alkaline phosphatase. Gastroenterology 62(3): 452\u2013468","journal-title":"Gastroenterology"},{"key":"1459_CR13","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1007\/BF01535953","volume":"33","author":"Reichling","year":"1988","unstructured":"Reichling JJ, Kaplan MM (1988) Clinical use of serum enzymes in liver disease. Dig Dis Sci 33(12): 1601\u20131614","journal-title":"Dig Dis Sci"},{"key":"1459_CR14","unstructured":"Vogt W, Holstege A (1997) Problem: Abkl\u00e4rung m\u00e4\u00dfig erh\u00f6hter Transaminasen und GGT. In: Sch\u00f6lmerich J, Bischoff SC, Manns MP (Hrsg) Diagnostik in der Gastroenterologie und Hepatologie. Thieme, Stuttgart, S\u00a0151\u2013160"},{"key":"1459_CR15","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1055\/s-2008-1069155","volume":"109","author":"Schmidt","year":"1984","unstructured":"Schmidt E, Schmidt FW (1984) Diagnosis of icterus. Dtsch Med Wochenschr 109(4): 139\u2013144","journal-title":"Dtsch Med Wochenschr"},{"key":"1459_CR16","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1055\/s-2008-1069454","volume":"109","author":"Chemnitz","year":"1984","unstructured":"Chemnitz G, Schmidt E, Schmidt FW, Lobers J (1984) Diagnostic and prognostic significance of massively increased serum glutamate dehydrogenase activity. Dtsch Med Wochenschr 109(47): 1789\u20131793","journal-title":"Dtsch Med Wochenschr"},{"key":"1459_CR17","unstructured":"Schmidt E, Schmidt FW (1979) Modell Lebererkrankungen: Klinik. In: Lang H, Rick W, B\u00fcttner H (Hrsg) Validit\u00e4t klinisch-chemischer Befunde. Springer, Berlin Heidelberg New York, S\u00a092\u2013119"},{"key":"1459_CR18","unstructured":"Thomas L (2007) Labor und Diagnose, 7th edn. TH Books, Frankfurt"},{"key":"1459_CR19","unstructured":"Neef L, Nilius R, Haschen RJ (1979) Applications of electronic data processing in diagnosis of hepatobiliary diseases. In: Schmidt E, Schmidt FW (eds) Advances in clinical enzymology. Karger, Basel, p\u00a0257"},{"key":"1459_CR20","unstructured":"Doumas BT, Wu TW (1991) The measurement of bilirubin fractions in serum. Crit Rev Clin Lab Sci 28(5\u20136): 415\u2013445"},{"key":"1459_CR21","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00007691-200104000-00001","volume":"23","author":"Oellerich","year":"2001","unstructured":"Oellerich M, Armstrong VW (2001) The MEGX test: a tool for the real-time assessment of hepatic function. Ther Drug Monit 23(2): 81\u201392","journal-title":"Ther Drug Monit"},{"key":"1459_CR22","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1046\/j.0306-5251.2001.01182.x","volume":"53","author":"Swart","year":"2002","unstructured":"Swart EL, Hoven B van der, Groeneveld AB et al. (2002) Correlation between midazolam and lignocaine pharmacokinetics and MEGX formation in healthy volunteers. Br J Clin Pharmacol 53(2): 133\u2013139","journal-title":"Br J Clin Pharmacol"},{"key":"1459_CR23","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/j.1365-2044.1995.tb05849.x","volume":"50","author":"Schroter","year":"1995","unstructured":"Schroter J, Wandel C, Bohrer H et al. (1995) Lignocaine metabolite formation: an indicator for liver dysfunction and predictor of survival in surgical intensive care patients. Anaesthesia 50(10): 850\u2013854","journal-title":"Anaesthesia"},{"key":"1459_CR24","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1002\/hep.1840140614","volume":"14","author":"Oellerich","year":"1991","unstructured":"Oellerich M, Burdelski M, Lautz HU et al. (1991) Predictors of one-year pretransplant survival in patients with cirrhosis. Hepatology 14(6): 1029\u20131034","journal-title":"Hepatology"},{"key":"1459_CR25","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1600-0773.1999.tb02009.x","volume":"85","author":"Wang","year":"1999","unstructured":"Wang JS, Backman JT, Wen X et al. (1999) Fluvoxamine is a more potent inhibitor of lidocaine metabolism than ketoconazole and erythromycin in vitro. Pharmacol Toxicol 85(5): 201\u2013205","journal-title":"Pharmacol Toxicol"},{"key":"1459_CR26","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.transproceed.2006.01.049","volume":"38","author":"Faybik","year":"2006","unstructured":"Faybik P, Hetz H (2006) Plasma disappearance rate of indocyanine green in liver dysfunction. Transplant Proc 38(3): 801\u2013802","journal-title":"Transplant Proc"},{"key":"1459_CR27","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1378\/chest.122.5.1715","volume":"122","author":"Sakka","year":"2002","unstructured":"Sakka SG, Reinhart K, Meier-Hellmann A (2002) Prognostic value of the indocyanine green plasma disappearance rate in critically ill patients. Chest 122(5): 1715\u20131720","journal-title":"Chest"},{"key":"1459_CR28","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1097\/00003246-200106000-00014","volume":"29","author":"Kimura","year":"2001","unstructured":"Kimura S, Yoshioka T, Shibuya M et al. (2001) Indocyanine green elimination rate detects hepatocellular dysfunction early in septic shock and correlates with survival. Crit Care Med 29(6): 1159\u20131163","journal-title":"Crit Care Med"},{"key":"1459_CR29","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1164\/ajrccm.160.6.9708113","volume":"160","author":"Joly","year":"1999","unstructured":"Joly LM, Monchi M, Cariou A et al. (1999) Effects of dobutamine on gastric mucosal perfusion and hepatic metabolism in patients with septic shock. Am J Respir Crit Care Med 160(6): 1983\u20131986","journal-title":"Am J Respir Crit Care Med"},{"key":"1459_CR30","first-page":"208","volume":"3","author":"Frederic","year":"1983","unstructured":"Frederic N, Deltenre M, d\u2019Hondt M et al. (1983) Comparative study of ultrasound and ERCP in the diagnosis of hepatic, biliary and pancreatic diseases: a prospective study based on a continuous series of 424 patients. Eur J Radiol 3(3): 208\u2013211","journal-title":"Eur J Radiol"},{"key":"1459_CR31","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1001\/archinte.1994.00420220069008","volume":"154","author":"Shea","year":"1994","unstructured":"Shea JA, Berlin JA, Escarce JJ et al. (1994) Revised estimates of diagnostic test sensitivity and specificity in suspected biliary tract disease. Arch Intern Med 154(22): 2573\u20132581","journal-title":"Arch Intern Med"},{"key":"1459_CR32","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/jcu.1870100305","volume":"10","author":"Ralls","year":"1982","unstructured":"Ralls PW, Halls J, Lapin SA et al. (1982) Prospective evaluation of the sonographic Murphy sign in suspected acute cholecystitis. J Clin Ultrasound 10(3): 113\u2013115","journal-title":"J Clin Ultrasound"},{"key":"1459_CR33","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/jcu.1870190203","volume":"19","author":"Stott","year":"1991","unstructured":"Stott MA, Farrands PA, Guyer PB et al. (1991) Ultrasound of the common bile duct in patients undergoing cholecystectomy. J Clin Ultrasound 19(2): 73\u201376","journal-title":"J Clin Ultrasound"},{"key":"1459_CR34","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1572-0241.2001.03594.x","volume":"96","author":"Masci","year":"2001","unstructured":"Masci E, Toti G, Mariani A et al. (2001) Complications of diagnostic and therapeutic ERCP: a prospective multicenter study. Am J Gastroenterol 96(2): 417\u2013423","journal-title":"Am J Gastroenterol"},{"key":"1459_CR35","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00261-004-0227-y","volume":"30","author":"Zandrino","year":"2005","unstructured":"Zandrino F, Curone P, Benzi L et al. (2005) MR versus multislice CT cholangiography in evaluating patients with obstruction of the biliary tract. Abdom Imaging 30(1): 77\u201385","journal-title":"Abdom Imaging"},{"key":"1459_CR36","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1007\/s00330-004-2327-z","volume":"14","author":"Zech","year":"2004","unstructured":"Zech CJ, Schoenberg SO, Reiser M, Helmberger T (2004) Cross-sectional imaging of biliary tumors: current clinical status and future developments. Eur Radiol 14(7): 1174\u20131187","journal-title":"Eur Radiol"},{"key":"1459_CR37","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3949\/ccjm.72.3.199","volume":"72","author":"Siegel","year":"2005","unstructured":"Siegel CA, Silas AM, Suriawinata AA, Leeuwen DJ van (2005) Liver biopsy 2005: when and how? Cleve Clin J Med 72(3): 199\u2013201, 206, 208","journal-title":"Cleve Clin J Med"},{"key":"1459_CR38","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1186\/cc5674","volume":"11","author":"Kredel","year":"2007","unstructured":"Kredel M, Muellenbach RM, Brock RW et al. (2007) Liver dysfunction after lung recruitment manoeuvres during pressure-controlled ventilation in experimental acute respiratory distress. Crit Care 11(1): R13","journal-title":"Crit Care"},{"key":"1459_CR39","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1399-6576.1993.tb03742.x","volume":"37","author":"Fujita","year":"1993","unstructured":"Fujita Y (1993) Effects of PEEP on splanchnic hemodynamics and blood volume. Acta Anaesthesiol Scand 37(4): 427\u2013431","journal-title":"Acta Anaesthesiol Scand"},{"key":"1459_CR40","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1152\/jappl.1987.62.4.1377","volume":"62","author":"Matuschak","year":"1987","unstructured":"Matuschak GM, Pinsky MR, Rogers RM (1987) Effects of positive end-expiratory pressure on hepatic blood flow and performance. J Appl Physiol 62(4): 1377\u20131383","journal-title":"J Appl Physiol"},{"key":"1459_CR41","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1097\/00003246-198711000-00010","volume":"15","author":"Sha","year":"1987","unstructured":"Sha M, Saito Y, Yokoyama K et al. (1987) Effects of continuous positive-pressure ventilation on hepatic blood flow and intrahepatic oxygen delivery in dogs. Crit Care Med 15(11):1040\u20131043","journal-title":"Crit Care Med"},{"key":"1459_CR42","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/j.1365-2036.2006.03117.x","volume":"24","author":"Valle","year":"2006","unstructured":"Valle MB de, Klinteberg V Av, Alem N et al. (2006) Drug-induced liver injury in a Swedish University hospital out-patient hepatology clinic. Aliment Pharmacol Ther 24(8): 1187\u20131195","journal-title":"Aliment Pharmacol Ther"},{"key":"1459_CR43","first-page":"1873","volume":"95","author":"Schattenberg","year":"2006","unstructured":"Schattenberg JM, Galle PR, Schuchmann M (2006) Acute liver failure \u2013 Medical viewpoints. Schweiz Rundsch Med Prax 95(48): 1873\u20131877","journal-title":"Schweiz Rundsch Med Prax"},{"key":"1459_CR44","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/hep.20800","volume":"42","author":"Bjornsson","year":"2005","unstructured":"Bjornsson E, Olsson R et al. (2005) Outcome and prognostic markers in severe drug-induced liver disease. Hepatology 42(2):481\u2013489","journal-title":"Hepatology"},{"key":"1459_CR45","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.gastro.2005.05.006","volume":"129","author":"Andrade","year":"2005","unstructured":"Andrade RJ, Lucena MI, Fernandez MC et al. (2005) Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology 129(2): 512\u2013521","journal-title":"Gastroenterology"},{"key":"1459_CR46","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1053\/jhep.2002.34857","volume":"36","author":"Sgro","year":"2002","unstructured":"Sgro C, Clinard F, Ouazir K et al. (2002) Incidence of drug-induced hepatic injuries: a French population-based study. Hepatology 36(2): 451\u2013455","journal-title":"Hepatology"},{"key":"1459_CR47","first-page":"268","volume":"20","author":"Bonet","year":"2005","unstructured":"Bonet A, Grau T (2005) Multicenter study on incidence of total parenteral nutrition complications in the critically-ill patient. ICOMEP study. Part I. Nutr Hosp 20(4): 268\u2013277","journal-title":"Nutr Hosp"},{"key":"1459_CR48","doi-asserted-by":"crossref","first-page":"R10","DOI":"10.1186\/cc5670","volume":"11","author":"Grau","year":"2007","unstructured":"Grau T, Bonet A, Rubio M et al. (2007) Liver dysfunction associated with artificial nutrition in critically ill patients. Crit Care 11(1): R10","journal-title":"Crit Care"},{"key":"1459_CR49","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1139\/y96-029","volume":"74","author":"Lautt","year":"1996","unstructured":"Lautt WW (1996) The 1995 Ciba-Geigy award lecture. Intrinsic regulation of hepatic blood flow. Can J Physiol Pharmacol 74(3): 223\u2013233","journal-title":"Can J Physiol Pharmacol"},{"key":"1459_CR50","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1440-1746.1993.tb01647.x","volume":"8","author":"Shibayama","year":"1993","unstructured":"Shibayama Y, Urano T, Asaka S et al. (1993) Pathogenesis of centrilobular necrosis following congestion of the liver. J Gastroenterol Hepatol 8(6): 530\u2013534","journal-title":"J Gastroenterol Hepatol"},{"key":"1459_CR51","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1001\/archsurg.1990.01410160027004","volume":"125","author":"Dahn","year":"1990","unstructured":"Dahn MS, Wilson RF, Lange P et al. (1990) Hepatic parenchymal oxygen tension following injury and sepsis. Arch Surg 125(4): 441\u2013443","journal-title":"Arch Surg"},{"key":"1459_CR52","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/01.md.0000101573.54295.bd","volume":"82","author":"Henrion","year":"2003","unstructured":"Henrion J, Schapira M, Luwaert R et al. (2003) Hypoxic hepatitis: clinical and hemodynamic study in 142 consecutive cases. Medicine 82(6): 392\u2013406","journal-title":"Medicine"},{"key":"1459_CR53","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/hep.510290202","volume":"29","author":"Henrion","year":"1999","unstructured":"Henrion J, Minette P, Colin L et al. (1999) Hypoxic hepatitis caused by acute exacerbation of chronic respiratory failure: a case-controlled, hemodynamic study of 17 consecutive cases. Hepatology 29(2): 427\u2013433","journal-title":"Hepatology"},{"key":"1459_CR54","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/j.1572-0241.2007.01118.x","volume":"102","author":"Gelbmann","year":"2007","unstructured":"Gelbmann CM, Rummele P, Wimmer M et al. (2007) Ischemic\u2013like cholangiopathy with secondary sclerosing cholangitis in critically ill patients. Am J Gastroenterol 102(6): 1221\u20131229","journal-title":"Am J Gastroenterol"},{"key":"1459_CR55","first-page":"74","volume":"2","author":"Luketic","year":"1994","unstructured":"Luketic VA, Sanyal AJ (1994) The current status of ursodeoxycholate in the treatment of chronic cholestatic liver disease. Gastroenterologist 2(1): 74\u201379","journal-title":"Gastroenterologist"},{"key":"1459_CR56","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1124\/dmd.31.12.1499","volume":"31","author":"James","year":"2003","unstructured":"James LP, Mayeux PR, Hinson JA (2003) Acetaminophen-induced hepatotoxicity. Drug Metab Dispos 31(12): 1499\u20131506","journal-title":"Drug Metab Dispos"},{"key":"1459_CR57","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1081\/CLT-120014646","volume":"40","author":"Enjalbert","year":"2002","unstructured":"Enjalbert F, Rapior S, Nouguier-Soule J et al. (2002) Treatment of amatoxin poisoning: 20-year retrospective analysis. J Toxicol Clin Toxicol 40(6): 715\u2013757","journal-title":"J Toxicol Clin Toxicol"},{"key":"1459_CR58","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.gtc.2006.10.002","volume":"35","author":"Hollinger","year":"2006","unstructured":"Hollinger FB, Lau DT (2006) Hepatitis\u00a0B: the pathway to recovery through treatment. Gastroenterol Clin North Am 35(4): 895\u2013931","journal-title":"Gastroenterol Clin North Am"},{"key":"1459_CR59","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/ncpgasthep0143","volume":"2","author":"Senzolo","year":"2005","unstructured":"Senzolo M, Cholongitas EC, Patch D, Burroughs AK (2005) Update on the classification, assessment of prognosis and therapy of Budd-Chiari syndrome. Nat Clin Pract Gastroenterol Hepatol 2(4): 182\u2013190","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"1459_CR60","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S0140-6736(02)07743-7","volume":"359","author":"Bernal","year":"2002","unstructured":"Bernal W, Donaldson N, Wyncoll D, Wendon J et al. (2002) Blood lactate as an early predictor of outcome in paracetamol-induced acute liver failure: a cohort study. Lancet 359(9306): 558\u2013563","journal-title":"Lancet"},{"key":"1459_CR61","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/hep.510230122","volume":"23","author":"Arroyo","year":"1996","unstructured":"Arroyo V, Gines P, Gerbes AL et al. (1996) Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology 23(1): 164\u2013176","journal-title":"Hepatology"},{"key":"1459_CR62","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/j.1440-1746.2004.03471.x","volume":"19","author":"Witzke","year":"2004","unstructured":"Witzke O, Baumann M, Patschan D et al. (2004) Which patients benefit from hemodialysis therapy in hepatorenal syndrome? J Gastroenterol Hepatol 19(12): 1369\u20131373","journal-title":"J Gastroenterol Hepatol"},{"key":"1459_CR63","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jhep.2007.04.010","volume":"47","author":"Alessandria","year":"2007","unstructured":"Alessandria C, Ottobrelli A, Debernardi-Venon W et al. (2007) Noradrenalin vs terlipressin in patients with hepatorenal syndrome: a prospective, randomized, unblinded, pilot study. J Hepatol 47(4): 499\u2013505","journal-title":"J Hepatol"},{"key":"1459_CR64","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1053\/jhep.2002.35819","volume":"36","author":"Ortega","year":"2002","unstructured":"Ortega R, Gines P, Uriz J et al. (2002) Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study. Hepatology 36(4 Pt1): 941\u2013948","journal-title":"Hepatology"},{"key":"1459_CR65","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.jhep.2007.01.011","volume":"46","author":"Blei","year":"2007","unstructured":"Blei AT (2007) Brain edema in acute liver failure: can it be prevented? Can it be treated? J Hepatol 46(4): 564\u2013569","journal-title":"J Hepatol"},{"key":"1459_CR66","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0002-9343(02)01477-8","volume":"114","author":"Ong","year":"2003","unstructured":"Ong JP, Aggarwal A, Krieger D et al. (2003) Correlation between ammonia levels and the severity of hepatic encephalopathy. Am J Med 114(3): 188\u2013193","journal-title":"Am J Med"},{"key":"1459_CR67","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1023\/A:1021934607762","volume":"17","author":"Kircheis","year":"2002","unstructured":"Kircheis G, Wettstein M, Dahl S, Haussinger D (2002) Clinical efficacy of L-ornithine-L-aspartate in the management of hepatic encephalopathy. Metab Brain Dis 17(4): 453\u2013462","journal-title":"Metab Brain Dis"},{"key":"1459_CR68","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1002\/hep.21930","volume":"46","author":"Hassanein","year":"2007","unstructured":"Hassanein TI, Tofteng F, Brown RS Jr et al. (2007) Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis. Hepatology 46(6): 1853\u20131862","journal-title":"Hepatology"},{"key":"1459_CR69","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1046\/j.1525-1594.1999.06122.x","volume":"23","author":"Stange","year":"1999","unstructured":"Stange J, Mitzner SR, Risler T et al. (1999) Molecular adsorbent recycling system (MARS): clinical results of a new membrane-based blood purification system for bioartificial liver support. Artif Organs 23(4): 319\u2013330","journal-title":"Artif Organs"},{"key":"1459_CR70","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/cc5922","volume":"11","author":"Karvellas","year":"2007","unstructured":"Karvellas CJ, Gibney N, Kutsogiannis D et al. (2007) Bench-to-bedside review: current evidence for extracorporeal albumin dialysis systems in liver failure. Crit Care 11(3): 215","journal-title":"Crit Care"}],"container-title":["Der Anaesthesist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-008-1459-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00101-008-1459-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-008-1459-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T02:57:05Z","timestamp":1558580225000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00101-008-1459-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,8]]},"references-count":70,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["1459"],"URL":"https:\/\/doi.org\/10.1007\/s00101-008-1459-y","relation":{},"ISSN":["0003-2417","1432-055X"],"issn-type":[{"value":"0003-2417","type":"print"},{"value":"1432-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,8]]}}}